Redox Potential-Sensitive N-Acetyl Cysteine-Prodrug Nanoparticles Inhibit the Activation of Microglia and Improve Neuronal Survival.
One hallmark of neuroinflammation is the activation of microglia, which triggers the production and release of reactive oxygen species (ROS), nitrate, nitrite, and cytokines. N-Acetyl cysteine (NAC) is a free radical scavenger that is involved in the intracellular and extracellular detoxification of reactive oxygen species in the brain. However, the clinical application of NAC is limited by its low bioavailability and short half-life. Herein, NAC was conjugated to a polymer through a disulfide bond to form a NAC-prodrug nanoparticle (NAC-NP). Dynamic light scattering found that the NAC-NP has a size of around 50 nm. In vitro studies revealed that the release of NAC from NAC-NP is responsive to its environmental redox potential. For mimicking neuroinflammation in vitro, microglial cells were stimulated by a lipopolysaccharide (LPS), and the effect of NAC-NP on activated microglia was investigated. The study found that the morphology as well as the expression of microgliosis marker Iba-1 of the cells treated with NAC-NPs and LPS were close to those of control cells, indicating that NAC-NPs can inhibit the activation of microglia stimulated by LPS. Compared with free NAC, the production of ROS, NO3-, NO2-, tumor necrosis factor-α (TNF-α), and interleukin (IL)-1β from the LPS-stimulated microglia was considerably decreased when the cells were pretreated with NAC-NPs. Furthermore, LPS-induced microglial phagocytocis of neurons was inhibited in the presence of NAC-NPs. These results indicated that NAC-NPs are more effective than free NAC for reversing the effect of LPS on microglia and subsequently protecting neurons.
Department of Drug Discovery and Biomedical Sciences, College of Pharmacy, University of South Carolina , 715 Sumter Street, Columbia, South Carolina 29208, United States.
Eleni
E
Markoutsa
Department of Drug Discovery and Biomedical Sciences, College of Pharmacy, University of South Carolina , 715 Sumter Street, Columbia, South Carolina 29208, United States.
Peisheng
0000-0002-4486-7058
P
Xu
D000111:Acetylcysteine / Q000737:chemistry*; D000818:Animals; D000975:Antioxidants / Q000378:metabolism; D002460:Cell Line; D007150:Immunohistochemistry; D053583:Interleukin-1beta / Q000378:metabolism; D008070:Lipopolysaccharides / Q000494:pharmacology; D051379:Mice; D017628:Microglia / Q000166:cytology* / Q000187:drug effects* / Q000378:metabolism; D053758:Nanoparticles / Q000737:chemistry*; D009474:Neurons / Q000166:cytology* / Q000187:drug effects* / Q000378:metabolism; D010084:Oxidation-Reduction / Q000187:drug effects; D011355:Prodrugs / Q000737:chemistry*; D017382:Reactive Oxygen Species / Q000378:metabolism
D000975:Antioxidants; D053583:Interleukin-1beta; D008070:Lipopolysaccharides; D011355:Prodrugs; D017382:Reactive Oxygen Species; D000111:Acetylcysteine
N-acetyl cysteine; anti-inflammatory; antioxidant; nanoparticle; prodrug; redox potential-sensitive